# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-25-000081
Filing Date
2025-08-07
Accepted
2025-08-07 16:15:59
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CIDARA THERAPEUTICS, INC. FORM 10-Q | cdtx-20250630.htm iXBRL | 10-Q | 1475963
2 | CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3112025-06.htm | EX-31.1 | 10345
3 | CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3122025-06.htm | EX-31.2 | 10289
4 | CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3212025-06.htm | EX-32.1 | 7820
5 | CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3222025-06.htm | EX-32.2 | 7807
| Complete submission text file | 0001610618-25-000081.txt |  | 7649808

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cdtx-20250630.xsd | EX-101.SCH | 47198
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cdtx-20250630_cal.xml | EX-101.CAL | 71374
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cdtx-20250630_def.xml | EX-101.DEF | 315861
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cdtx-20250630_lab.xml | EX-101.LAB | 684765
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cdtx-20250630_pre.xml | EX-101.PRE | 514681
69 | EXTRACTED XBRL INSTANCE DOCUMENT | cdtx-20250630_htm.xml | XML | 924590

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 251194247
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)